| Megan Kudlac, DPT | |
|
10803 Falls Rd, Suite 2100, Lutherville, MD 21093-4535 | |
| (443) 997-5476 | |
| (410) 847-3838 |
| Full Name | Megan Kudlac |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 10803 Falls Rd, Lutherville, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073172870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20041115000337 |
News Archive
Contrary to popular belief, purified drinking water from home faucets contains millions to hundreds of millions of widely differing bacteria per gallon, and scientists have discovered a plausible way to manipulate those populations of mostly beneficial microbes to potentially benefit consumers. Their study appears in ACS' journal Environmental Science & Technology.
A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates the uptake, transport and utilization of iron for cellular function, increasing cell growth and productivity. Native transferrin found in bovine or human serum has been widely used in cell culture for these added benefits. However, regulatory issues continue to arise with the use of native transferrin due to blood-borne pathogens.
Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010.
A new study looking at the effects of the 2006 Massachusetts Health Reform on access to care, health status and ethnic and socioeconomic disparities in healthcare, shows that the legislation has led to improvements in insurance coverage as well as a decline in financial barriers to care. However, to date, it has not increased people's access to a personal physician or improved their self-rated health. Neither has it reduced healthcare inequalities between ethnic or income groups.
OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Kudlac, DPT 10803 Falls Rd, Suite 2100, Lutherville, MD 21093-4535 Ph: () - | Megan Kudlac, DPT 10803 Falls Rd, Suite 2100, Lutherville, MD 21093-4535 Ph: (443) 997-5476 |
News Archive
Contrary to popular belief, purified drinking water from home faucets contains millions to hundreds of millions of widely differing bacteria per gallon, and scientists have discovered a plausible way to manipulate those populations of mostly beneficial microbes to potentially benefit consumers. Their study appears in ACS' journal Environmental Science & Technology.
A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates the uptake, transport and utilization of iron for cellular function, increasing cell growth and productivity. Native transferrin found in bovine or human serum has been widely used in cell culture for these added benefits. However, regulatory issues continue to arise with the use of native transferrin due to blood-borne pathogens.
Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010.
A new study looking at the effects of the 2006 Massachusetts Health Reform on access to care, health status and ethnic and socioeconomic disparities in healthcare, shows that the legislation has led to improvements in insurance coverage as well as a decline in financial barriers to care. However, to date, it has not increased people's access to a personal physician or improved their self-rated health. Neither has it reduced healthcare inequalities between ethnic or income groups.
OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.
› Verified 8 days ago
Medstar Health Physical Therapy Lutherville Hand Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Front Ave Ste 205, Lutherville, MD 21093 Phone: 410-823-4263 Fax: 410-823-1861 | |
Dr. Robert Daniel Scheeler, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 Brightfield Rd, Lutherville, MD 21093 Phone: 410-296-1990 | |
Dr. Jessica Abraskin, PT,DPT,CBIS Physical Therapist Medicare: Medicare Enrolled Practice Location: 10753 Falls Rd, Suite 235, Lutherville, MD 21093 Phone: 410-583-2665 | |
Laura Teasley, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10803 Falls Rd Ste 2100, Lutherville, MD 21093 Phone: 410-583-2665 | |
Active Life Pt Physical Therapist Medicare: Medicare Enrolled Practice Location: 1447 York Rd, Suite 401, Lutherville, MD 21093 Phone: 410-529-3303 Fax: 410-529-7980 | |
Latai Camile Jenkins, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10753 Falls Rd, Suite 235, Lutherville, MD 21093 Phone: 410-583-2665 Fax: 410-847-3838 |